Arrow-right Camera

The Spokesman-Review Newspaper The Spokesman-Review

Sunday, October 25, 2020  Spokane, Washington  Est. May 19, 1883
Clear Day 31° Clear
News >  Pacific NW

State settles case over Medicaid coverage of hepatitis drugs

Associated Press

YAKIMA – The agency that administers Medicaid in Washington state has reached a tentative settlement of a class-action lawsuit that sought broader coverage of expensive hepatitis C drugs.

The Yakima Herald-Republic reported the Washington Health Care Authority has agreed to provide the medicine to all hepatitis C patients, not just the sickest ones.

Previously, the state based coverage of the drugs on a “fibrosis” score that measures scarring on the liver, and it would only provide the drugs to patients with advanced liver disease.

The drugs can cure the disease in more than 90 percent of patients, but they can cost about $95,000 for a 12-week course.

The lawsuit alleged that 900 people had been denied access to the drugs based on their fibrosis score.

The judge has yet to approve the settlement.

The Spokesman-Review Newspaper

Local journalism is essential.

Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.

Subscribe to the Coronavirus newsletter

Get the day’s latest Coronavirus news delivered to your inbox by subscribing to our newsletter.


New health insurance plans available Nov. 1 through Washington Healthplanfinder

 (Photo courtesy WAHBE)
Sponsored

Fall means the onset of the cold and flu season.